StockLumo

Beyond Air, Inc. (XAIR): Form 8-K filed 2026-11-13

Accepted by EDGAR
2026-11-13 17:00 ET
Event date
2026-11-11
Accession no.
0001493152-26-051810
Original filing
SEC EDGAR filing index

AI summary of the filing text. It can contain mistakes; the original filing is authoritative.

Beyond Air reports quarterly results and reaffirms revenue guidance

Beyond Air reported $2.3 million in revenue and a $7.8 million net loss attributed to common stockholders for the quarter ended September 30, 2026. It reaffirmed revenue guidance of $8 million for calendar year 2026 and $16 million to $18 million for calendar year 2027. The second-generation LungFit PH system remains under FDA review; the 2027 guidance includes anticipated revenue from that system, pending FDA approval.

earningsguidanceregulatory

Items reported

Documents

TypeDescriptionDocument
8-K8-Kform8-k.htm
EX-99.1EX-99.1ex99-1.htm

The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.